Using retained earnings for research and development, facilities and overseas investment
First written in FY2016. 17 of 19 entries say "Advanced", first in FY2017. Latest entry: FY2026.
21 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「During the consolidated fiscal year, the Group as a whole made capital investments of ¥12,629 million.」
¥12,629 million was invested in upgrading existing equipment, expanding chemical manufacturing and processing capacity, and enhancing assets for research and development. - 2026-06-04RestatedGeneral Meetings of Shareholders
「As a member of society, we will use retained earnings for future business investments based on sustainability management and work to enhance corporate value.」
The company has reaffirmed its policy of using retained earnings for future business investment. - FY2026-H1AdvancedAnnual report
「The status of each cash flow during the interim consolidated accounting period was as follows: ... Payments for the acquisition of property, plant and equipment: ¥6,354 million」
The company spent ¥6,354 million on the acquisition of property, plant and equipment during the interim consolidated accounting period, continuing its investment in facilities and growth. - FY2025AdvancedAnnual report
「During the consolidated fiscal year, the Group as a whole made capital investments of ¥13,673 million.」
¥13,673 million was invested in upgrading equipment, expanding chemical manufacturing and processing capacity, and enhancing assets for research and development, up from ¥8,976 million in the previous fiscal year. - FY2025-H1AdvancedAnnual report
「Payments for the acquisition of property, plant and equipment: ¥3,806 million」
The company spent ¥3,806 million on the acquisition of property, plant and equipment during the interim consolidated accounting period, continuing its investment in facilities and growth. - FY2024AdvancedAnnual report
「During the consolidated fiscal year, the Group as a whole made capital investments of ¥8,976 million.」
¥8,976 million was invested in fiscal 2024 in upgrading existing equipment, expanding chemical manufacturing and processing capacity, and enhancing assets for research and development. - FY2024-Q2AdvancedAnnual report
「This was mainly attributable to ¥3,460 million in proceeds from the withdrawal of time deposits, ¥2,988 million in payments for the acquisition of property, plant and equipment, and ¥2,431 million in payments for placing time deposits.」
The company spent ¥2,988 million on the acquisition of property, plant and equipment during the cumulative second-quarter period, continuing its investment in facilities and growth. - FY2023AdvancedAnnual report
「The group (the company and its consolidated subsidiaries) has continued to renew existing facilities to meet market needs, improve the quality of chemicals and expand production capacity, expand processing capacity, and enhance assets for R&D. During the consolidated fiscal year, the group as a whole made capital investments of ¥9,292 million.」
¥9,292 million was invested in upgrading equipment, expanding chemical and processing capacity, and enhancing assets for research and development, up from ¥4,514 million in the previous fiscal year. - FY2023-Q2AdvancedAnnual report
「Net cash used in investing activities increased by ¥376 million from the same period of the previous year to ¥1,835 million. The main expenditure was ¥3,168 million in payments for the acquisition of property, plant and equipment.」
During the cumulative second quarter, the company spent ¥3,168 million on the acquisition of property, plant and equipment and continued capital investment. - FY2022AdvancedAnnual report
「During the consolidated fiscal year, the group as a whole made capital investments of ¥4,514 million.」
The company invested ¥4,514 million in renewing existing facilities, expanding chemical production and processing capacity, and enhancing assets for R&D. - FY2022-Q2AdvancedAnnual report
「The main expenditure was ¥2,613 million in payments for the acquisition of property, plant and equipment.」
During the cumulative second quarter, the company spent ¥2,613 million on the acquisition of property, plant and equipment and continued capital investment. - FY2021-Q2AdvancedAnnual report
「The main expenditure was ¥2,421 million in payments for the acquisition of property, plant and equipment.」
During the cumulative second quarter of the consolidated fiscal year, the company spent ¥2,421 million on the acquisition of property, plant and equipment and continued capital investment. - FY2020AdvancedAnnual report
「During the consolidated fiscal year, the group as a whole made capital investments of ¥8,974 million.」
The company made capital investments of ¥8,974 million to renew existing facilities, expand production and processing capacity, and enhance assets for R&D. - FY2020-Q2AdvancedAnnual report
「Net cash used in investing activities increased by ¥43 million from the same period of the previous year to ¥4,790 million. The main component was ¥5,433 million in payments for the acquisition of property, plant and equipment.」
During the cumulative second quarter, the company spent ¥5,433 million on the acquisition of property, plant and equipment and continued capital investment. - FY2019AdvancedAnnual report
「During the consolidated fiscal year, the group as a whole made capital investments of ¥8,536 million.」
The company made capital investments of ¥8,536 million to renew existing facilities, expand production and processing capacity, and enhance assets for R&D. - FY2019-Q2AdvancedAnnual report
「Net cash used in investing activities increased by ¥1,849 million from the previous fiscal year to ¥4,746 million. The main component was ¥4,432 million in payments for the acquisition of property, plant and equipment.」
During the cumulative second quarter of the consolidated fiscal year, the company spent ¥4,432 million on the acquisition of property, plant and equipment and continued capital investment. - FY2018-Q2AdvancedAnnual report
「Net cash used in investing activities increased by ¥303 million from the previous fiscal year to ¥2,897 million. The main component was ¥3,044 million in payments for the acquisition of property, plant and equipment.」
During the cumulative second quarter, the company recorded ¥3,044 million in payments for the acquisition of property, plant and equipment and continued capital investment. - FY2017AdvancedAnnual report
「The group (the company and its consolidated subsidiaries) has continued to renew existing facilities to meet market needs, improve the quality of chemicals and expand production capacity, expand processing capacity, and enhance assets for R&D. During the consolidated fiscal year, the group as a whole made capital investments of ¥7,933 million.」
The company continued capital expenditure and R&D investment using retained earnings and other funds. Capital expenditure for the current fiscal year totaled ¥7,933 million. - FY2016First statedAnnual report
「Retained funds are being used for R&D addressing market needs, capital investment to achieve the quality and cost levels demanded by the market, and overseas investment.」
Alongside shareholder returns, retained earnings are being allocated to R&D, equipment to address quality and cost requirements, and overseas investment.